Committee for Pharmaceutical Development (CPD)

The goal of the Committee for Pharmaceutical Development (CPD) is to identify, develop, and commercialize pharmaceutical products by forming networks and fostering dialogue between University of Minnesota researchers and industry experts.

The CPD aims to boost the success rate of therapeutic development and commercialization.

The CPD includes University staff and external advisors with proven drug-development experience.

Funded technologies will have demonstrated persuasive indicators of commercial success and will show potential for improving human health.

Apply Now

Applications are accepted on a continuous basis.

Online LOI submission form

Learn more about the types of projects we prioritize

Please contact the Program Manager, Brittni Peterson, at bmpete@umn.edu with any questions.

Awardees

2019

James M. Ervasti, PhD, and David D. Thomas, PhD, and Joseph M. Muretta, PhD, Department of Biochemistry, Molecular Biology and Biophysics, Medical School

Project title: Mini-/Micro-Dystrophin Actin Binding Domain 1 Gain-of-Affinity

2018

Jon Hawkinson, PhD, Institute for Therapeutics Discovery & Development

Project title: Critical path studies to nominate BINTA as a preclinical development candidate to treat chronic pain devoid of opioid side effect liability

2016

George Wilcox, Daniel Bruce, Philip Portoghese, and Carolyn Fairbanks

Project title: Peripherally restricted combination therapy for inflammatory or cancer-related chronic pain

2015

Gwenyth Fischer, MD, Medical School, Department of Pediatrics

Project title: Epinephrine Drug-delivery Device for use in Pediatric Cardiac Arrest


Amber Lockridge, Medical School, Department of Neuroscience

Project title: The Use of D-serine as a Novel Insulin Secretagogue and Oral Antidiabetic

2014

Gregory Beilman, MD, Medical School, Department of Surgery

Project title: Beta-hydroxybutyrate/melatonin (BHB/M) for the Treatment of Trauma-induced Acute Blood Loss


Lester Drewes, PhD, Medical School, Department of Biomedical Sciences, and Venkatram Mereddy, PhD, College of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Sciences

Project title: Development of Novel Drugs for High Risk Triple Negative Breast Cancer Treatment


Jayanth Panyam, PhD, College of Pharmacy, Department of Pharmaceutics

Project title: Antibody Targeting Metastases in triple Negative Breast Cancer

2013

Jayanth Panyam, PhD, College of Pharmacy, Department of Pharmaceutics

Project title: Surface Functionalized Nanoparticles for Improved Chemotherapeutic Efficacy


Jayanth Panyam, PhD, College of Pharmacy, Department of Pharmaceutics

Project title: Silicate Prodrug Nanoparticles of Paclitaxel


Chun Wang, PhD, College of Science and Engineering, Department of Biomedical Engineering

Project title: Semi-solid Polymer Delivery Systems for Immunotherapy against Melanoma

2012

Daniel Vallera, PhD, Medical School, Department of Radiation Oncology

Project title: Developing Biological Drugs Targeting Chemo-Refractory Carcinoma


Carston R. Wagner, PhD, College of Pharmacy, Department of Medicinal Chemistry

Project title: In vivo Proof-of-Concept Studies on Chemically Self Assembled Nanostructures (CSANS) as Targeted Diagnostic Imaging and Drug Delivery agents for Brain Cancer

Contact us

Brittni Peterson, PhD
Program/Project Manager
Office of Discovery and Translation
bmpete@umn.edu
612-625-9442

Grantee spotlight

Greg BeilmanCTSI helps a potentially life-saving treatment advance closer to clinical trials